Alteration by xylocaine (lidocaine) and its derivatives of the time course of the end plate potential.
Xylocaine and its derivatives act specifically at the neuromuscular junction within the concentration range 0.05 to 2.0 mM. The charged form is the active form of the drugs. There is no correlation between "local anesthetic" activity and effect at the junction. Like d-tubocurarine, these drugs have little or no effect on quantum content, acetylcholinesterase activity, or the passive impedance of the muscle fiber. Yet they produce end plate potentials characterized by a brief, early component and a late, greatly prolonged component, as does procaine. Analysis of these changes in time course suggests that the drugs have little or no effect before receptors are activated by acetylcholine, but cause a decreased and often greatly prolonged response. Clear structure-activity relations indicate that the receptor to which the drugs bind to produce the prolonged response can be the receptor for acetylcholine. Comparison of the effects of the drugs on the end plate potential and on the response to iontophoretically applied acetylcholine also shows that the effects of Xylocaine depend on the time course of receptor activation and are quite different from the effects of d-tubocurarine.
D000109:Acetylcholine / Q000037:antagonists & inhibitors / Q000502:physiology; D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D001001:Anura; D001665:Binding Sites; D004594:Electrophysiology; D005071:Evoked Potentials / Q000187:drug effects*; D006863:Hydrogen-Ion Concentration; D007478:Iontophoresis; D008012:Lidocaine / Q000494:pharmacology*; D009469:Neuromuscular Junction / Q000187:drug effects* / Q000502:physiology; D011343:Procaine / Q000494:pharmacology; D017981:Receptors, Neurotransmitter / Q000187:drug effects; D013997:Time Factors
D017981:Receptors, Neurotransmitter; D011343:Procaine; D008012:Lidocaine; D000109:Acetylcholine